A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions

Pancreatic Disease

Interventions

DRUG

ChiRhoStim

Human Secretin for Injection

DRUG

Placebo

Saline for Injection

Trial Locations (1)

Saint Louis University, St Louis